Searched for
PHARMACEUTICAL MARKET NEWS
Why is Liquidia share price falling by nearly 50% today? US federal court ruling linked to lung drug Yutrepia explainedLiquidia stock dropped after a US federal court ruled that Liquidia's Yutrepia lung drug infringes two claims of a United Therapeutics pate...- In 1912, Wilfrid Voynich bought a mysterious manuscript written in an unknown script. 114 years later, its text remains undeciphered despite decades of studyIn 1912, Wilfrid Voynich purchased a mysterious manuscript from the Jesuit College at Frascati near Rome. Written in an unidentified script...
- 5 stocks with consistent score improvement and upside potential of up to 22% in 1 year, according to analystsGiven the current situation both globally and domestically, one can expect more headwinds in the market. There is, on the domestic front, a...
- These large- and mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos have upside potential of up to 25%, according to analystsTalk of tariffs, especially steep ones, makes the market nervous. Which is exactly why the next few trading sessions are critical, and why ...
- For investors who know and accept that bears can roam the street longer: 5 mid-cap stocks with upside potential of up to 29%It is when the market displays the kind of sentiment it is doing now that most investors develop a strong desire to just get out. That’s qu...
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the equity market, it is generally good to keep one eye on risk management. But there are times when it becomes a must-do. We are curren...
- Stocks in news: Swiggy, Adani Ports, IDFC First Bank, Hexaware Technologies and Sun PharmaIndian markets experienced a sharp decline on Wednesday due to global factors. Technical analysis suggests further downside potential for t...
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- India sends its Fab 4 across the world to woo trade, tech, energy and capitalIndia engages key partners, focusing on border management and energy security. Discussions with China now include investment alongside boun...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- India’s exports to US hold firm after a year of Trump’s tariffsThe US continues to account for about 20% of India’s exports despite tariff tensions and New Delhi’s push to diversify trade. New agreement...
- Thermo Fisher finds India the perfect lab; lab equipment maker steps up investments as drug companies focus on innovationThermo Fisher Scientific is amplifying its investment footprint in India, driven by the strong anticipated growth in the biosimilars and in...
- When the right audience is listening, partnerships become a strategic advantageFor brands targeting business decision-makers, visibility alone is not enough. Bosch’s partnership with ET demonstrates how credible platfo...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- Alembic Pharma gets USFDA approval for generic chronic constipation treatment tabletsAlembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of...
Load More
